Cleared Traditional

K943803 - JOSTRA HL-20 INTEGRATED PERFUSION SYSTEM

K943803 is an FDA 510(k) clearance for JOSTRA HL-20 INTEGRATED PERFUSION SYSTEM, manufactured by Janus Biomedical, Inc.. The device is a Class 2 Cardiovascular device with product code DTQ cleared through the Traditional 510(k) pathway after a 544-day FDA review.

K943803 · Janus Biomedical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1996
Decision
544d
Days
Class 2
Risk

K943803 is an FDA 510(k) clearance for the JOSTRA HL-20 INTEGRATED PERFUSION SYSTEM. Classified as Console, Heart-lung Machine, Cardiopulmonary Bypass (product code DTQ), Class II - Special Controls.

Submitted by Janus Biomedical, Inc. (Austin, US). The FDA issued a Cleared decision on January 30, 1996 after a review of 544 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Janus Biomedical, Inc. devices

FDA 510(k) Submission Details - K943803

510(k) Number K943803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1994
Decision Date January 30, 1996
Days to Decision 544 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
419d slower than avg
Panel avg: 125d · This submission: 544d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DTQ Device Classification - Class 2, Special Controls

Product Code DTQ Console, Heart-lung Machine, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTQ Console, Heart-lung Machine, Cardiopulmonary Bypass

All 38
Devices cleared under the same product code (DTQ) and FDA review panel - the closest regulatory comparables to K943803.
ADVANCED PERFUSION SYSTEM 1 (100/120 VOLT),ADVANCED PERFUSION SYSTEM 1 (220/240 VOLT, ROLLER PUMPS (6, 4 INCH
K022947 · Terumo Cardiovascular Systems Corp. · Mar 2003
STOCKERT COMPACT SYSTEM
K982014 · Stoeckert Instrumente · Sep 1998
AFFINITY BLOOD PUMP SYSTEM
K964017 · Avecor Cardiovascular, Inc. · Aug 1997
STOCKERT S3 ROLLER PUMP MODULE STOCKERT S3 CONSOLE
K950990 · Stoeckert Instrumente · Jan 1996
SARNS 8000 MODULAR PERFUSION SYSTEM
K915183 · 3M Health Care, Sarns · Jul 1992
SARNS 9000 HEART-LUNG CONSOLE
K871131 · 3M Health Care, Sarns · May 1987